Juric specializes in targeted cancer therapies, advancing the development of new agents against one of the most frequently mutated oncogenes in metastatic breast cancer and other advanced malignancies.

He is director of translational research at Termeer Center for Targeted Therapies at Mass. General.

He will be honored at the one hundred, an annual event to be held on June 10 at the Westin Boston Waterfront hotel.